Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques
- PMID: 25930064
- DOI: 10.1227/NEU.0000000000000779
Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques
Abstract
Background: Low-grade glioma (LGG) patients have increased life expectancy, so interest is high in the treatments that maximize cognition and quality of life.
Objective: To examine presurgical baseline cognitive deficits in a case series of LGG patients and determine cognitive effects of surgical resection with awake mapping.
Methods: We retrospectively assessed neurological deficits, subjective concerns from patient or caregiver, and cognitive deficits at baseline and postsurgery for 22 patients with newly diagnosed LGG who underwent baseline neuropsychological evaluation and magnetic resonance imaging before awake surgical resection with mapping. Twelve of the 22 patients returned for postoperative evaluation approximately 7 months after surgery.
Results: At baseline, 92% of patients/caregivers reported changes in cognition or mood. Neurological examinations and Montreal Cognitive Assessment Scale scores were largely normal; however, on many tests of memory and language, nearly half of individuals showed deficits. After surgery, 45% had no deficits on neurological examination, whereas 55% had only transient or mild difficulties. Follow-up neuropsychological testing found most performances stable to improved, particularly in language, although some patients showed declines on memory tasks.
Conclusion: Most LGG patients in this series presented with normal neurological examinations and cognitive screening, but showed subjective cognitive and mood concerns and cognitive decline on neuropsychological testing, suggesting the importance of comprehensive evaluation. After awake mapping, language tended to be preserved, but memory demonstrated decline in some patients. These results highlight the importance of establishing a cognitive baseline before surgical resection and further suggest that awake mapping techniques provide reasonable language outcomes in individuals with LGG in eloquent regions.
Similar articles
-
Supratotal Resection of Diffuse Frontal Lower Grade Gliomas with Awake Brain Mapping, Preserving Motor, Language, and Neurocognitive Functions.World Neurosurg. 2018 Nov;119:30-39. doi: 10.1016/j.wneu.2018.07.193. Epub 2018 Aug 1. World Neurosurg. 2018. PMID: 30075269
-
Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.J Neurosurg. 2011 Aug;115(2):232-9. doi: 10.3171/2011.3.JNS101333. Epub 2011 May 6. J Neurosurg. 2011. PMID: 21548750
-
Cognitive functioning early after surgery of gliomas in eloquent areas.J Neurosurg. 2012 Nov;117(5):831-8. doi: 10.3171/2012.7.JNS12263. Epub 2012 Aug 31. J Neurosurg. 2012. PMID: 22937930
-
Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible?Neurosurg Rev. 2018 Jan;41(1):133-139. doi: 10.1007/s10143-017-0918-9. Epub 2017 Nov 6. Neurosurg Rev. 2018. PMID: 29105013 Review.
-
Cognitive Profiles and Determinants of Eligibility for Awake Surgery in Non-Dominant Hemisphere Gliomas: A Narrative Review.Brain Behav. 2025 Jun;15(6):e70604. doi: 10.1002/brb3.70604. Brain Behav. 2025. PMID: 40444665 Free PMC article. Review.
Cited by
-
Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients.Neurosurgery. 2021 Nov 18;89(6):945-953. doi: 10.1093/neuros/nyaa552. Neurosurgery. 2021. PMID: 33586764 Free PMC article. Review.
-
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.J Neurooncol. 2025 Mar;172(1):99-152. doi: 10.1007/s11060-024-04871-4. Epub 2025 Jan 13. J Neurooncol. 2025. PMID: 39806106
-
Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models.Methods Enzymol. 2020;631:91-106. doi: 10.1016/bs.mie.2019.05.032. Epub 2019 Jun 8. Methods Enzymol. 2020. PMID: 31948569 Free PMC article.
-
The clinical and neurocognitive functional changes with awake brain mapping for gliomas invading eloquent areas: Institutional experience and the utility of The Montreal Cognitive Assessment.Front Oncol. 2023 Feb 22;13:1086118. doi: 10.3389/fonc.2023.1086118. eCollection 2023. Front Oncol. 2023. PMID: 36910631 Free PMC article.
-
Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors.Curr Treat Options Neurol. 2019 Jun 28;21(7):33. doi: 10.1007/s11940-019-0573-2. Curr Treat Options Neurol. 2019. PMID: 31250277 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical